The market for Hormones in Dosage Except Contraceptives and Antibiotics in Colombia has shown a fluctuating trend from 2013 to 2023. By 2023, the market stood at 647.38 million USD, showcasing a modest year-on-year growth of 2.03% after a decline in 2022. Historically, the market experienced varied growth rates, with significant increases in specific years such as 2014 and 2020 and a notable decline in 2015. The compound annual growth rate (CAGR) from 2018 to 2023 was relatively low at 1.83%, indicating a sluggish overall growth in recent years.

For future trends:

Watch for technological advancements in hormone therapies.
Increased focus on personalized medicine could fuel demand.
Regulatory changes may impact market dynamics.
Economic factors and healthcare policy will be pivotal in shaping future growth.